| Assay ID | Title | Year | Journal | Article |
|---|
| AID313265 | Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222938 | Elimination half life in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222915 | Drug transport in Xenopus laevis oocytes assessed as recombinant human ENT1-mediated uptake up to 1 mM measured per 2 mins by Michaelis-Menten equation analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222942 | AUC (0 to infinity) in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222902 | Drug transport in yeast assessed as recombinant human ENT1-mediated uptake at 1 uM measured over 2 to 60 mins by scintillation counting analysis in absence of uridine | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313267 | Selectivity for human adenosine A1 receptor over human adenosine A2A receptor | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222925 | AUC (0 to 4 hrs) in CD-1 mouse brain at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222914 | Drug uptake in water-injected Xenopus laevis oocytes up to 1 mM measured per 2 mins | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID32599 | Binding affinity for adenosine A1 receptor determined using hamster DDT1 cell membranes with [3H]CCPA as radioligand | 2004 | Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
| Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF). |
| AID1222927 | AUC (0 to 4 hrs) in CD-1 mouse brain at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222934 | Apparent total clearance in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313257 | Displacement of [3H]CGS21680 from adenosine A1 receptor in bovine striatum membrane | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222911 | Drug transport in yeast assessed as recombinant human ENT2-mediated uptake at 1 uM measured over 60 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222908 | Binding affinity to recombinant human CNT2 expressed in Saccharomyces cerevisiae assessed as inhibition of [3H]-uridine transport after 15 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313262 | Agonist activity at adenosine A1 receptor in pig cortical membrane assessed as stimulation of GTPgammaS binding relative to CPA | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222909 | Binding affinity to recombinant human CNT3 expressed in Saccharomyces cerevisiae assessed as inhibition of [3H]-uridine transport after 5 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222937 | Elimination half life in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID303651 | Intrinsic activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as maximal inhibition of (-)-isoproterenol-stimulated cAMP accumulation | 2007 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 17, Issue:24
| Structure-activity relationships of adenosines with heterocyclic N6-substituents. |
| AID73328 | Binding affinity against GTPgammaS receptor using [35S]GTP-gamma-S, radioligand in guinea pig. | 2004 | Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
| Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents. |
| AID1222917 | Drug transport in Xenopus laevis oocytes assessed as recombinant human CNT2-mediated uptake by measuring induction of sodium currents at 100 to 500 uM by electrophysiological method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222946 | Drug transport in human CCRF-CEM cells assessed as ENT1-mediated uptake after 5 secs by Michaelis-Menten equation analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID303652 | Displacement of [3H]ZM-241385 from adenosine A2A receptor expressed in PC12 cell membrane | 2007 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 17, Issue:24
| Structure-activity relationships of adenosines with heterocyclic N6-substituents. |
| AID1222906 | Binding affinity to recombinant human ENT2 expressed in Saccharomyces cerevisiae assessed as inhibition of [3H]-uridine transport after 15 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222907 | Binding affinity to recombinant human CNT1 expressed in Saccharomyces cerevisiae assessed as inhibition of [3H]-uridine transport after 15 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID32452 | Binding affinity against adenosine A1 receptor using [3H]CPX in guinea pig DDT membrane; 543+/-182 | 2004 | Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
| Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents. |
| AID1222916 | Drug transport in Xenopus laevis oocytes assessed as recombinant human CNT1-mediated uptake by measuring induction of sodium currents at 100 to 500 uM by electrophysiological method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID78656 | Agonist-induced SH prolongation in guinea pig isolated heart was determined; 3-5 uM (Partial agonist) | 2004 | Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
| Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF). |
| AID1222930 | Apparent volume of distribution at steady state in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313269 | Selectivity for human adenosine A3 receptor over human adenosine A2A receptor | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID313255 | Displacement of [3H]CCPA from adenosine A1 receptor in bovine cortical membrane | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID32463 | Stimulation of binding of [35S]GTP uM) | 2004 | Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
| Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF). |
| AID1571133 | Displacement of [3H]DPCPX from pig A1 receptor | 2018 | MedChemComm, Nov-01, Volume: 9, Issue:11
| Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A |
| AID1222918 | Drug transport in Xenopus laevis oocytes assessed as recombinant human CNT3-mediated uptake by measuring induction of sodium currents at 100 to 500 uM by electrophysiological method | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222931 | Apparent total clearance in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222912 | Drug transport in human CCRF-CEM cells assessed as ENT1-mediated uptake measured per 10'6 cells after 5 secs by Michaelis-Menten equation analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID303650 | Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation | 2007 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 17, Issue:24
| Structure-activity relationships of adenosines with heterocyclic N6-substituents. |
| AID1222904 | Tmax in CD-1 mouse brain at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222905 | Binding affinity to recombinant human ENT1 expressed in Saccharomyces cerevisiae assessed as inhibition of [3H]-uridine transport after 15 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222922 | Cmax in CD-1 mouse brain at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1571138 | Displacement of [125I]I-AB-MECA from recombinant human adenosine A3 receptor expressed in CHO cell membranes | 2018 | MedChemComm, Nov-01, Volume: 9, Issue:11
| Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A |
| AID1222913 | Drug transport in human CCRF-CEM cells assessed as ENT1-mediated uptake at 10 uM after 1 to 60 mins by liquid scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222945 | Drug transport in Xenopus laevis oocytes assessed as recombinant human ENT1-mediated uptake up to 1 mM by Michaelis-Menten equation analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313256 | Displacement of [3H]CCPA from adenosine A1 receptor in pig cortical membrane | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222910 | Drug transport in yeast assessed as recombinant human ENT2-mediated uptake at 1 uM measured over 2 mins by scintillation counting analysis | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313268 | Selectivity for human adenosine A1 receptor over human adenosine A3 receptor | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID313266 | Agonist activity at human recombinant adenosine A2B receptor expressed in CHO cells assessed as activation of adenylyl cyclase activity | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222921 | Cmax in CD-1 mouse brain at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222941 | AUC (0 to infinity) in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313261 | Agonist activity at adenosine A1 receptor in pig cortical membrane assessed as stimulation of GTPgammaS binding | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID313263 | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID32309 | Binding affinity against adenosine A1 receptor using [3H]CCPA in guinea pig DDT membrane; 3.25+/-0.74 | 2004 | Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
| Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents. |
| AID1222903 | Tmax in CD-1 mouse brain at 0.1 mg/kg, iv administered as bolus dose in presence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID1222929 | Apparent volume of distribution at steady state in CD-1 mouse at 0.1 mg/kg, iv administered as bolus dose in absence of ENT1 inhibitor NBMPR-P | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID303649 | Displacement of [3H]CPX from adenosine A1 receptor expressed in DDT1 MF2 cells | 2007 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 17, Issue:24
| Structure-activity relationships of adenosines with heterocyclic N6-substituents. |
| AID1571134 | Displacement of [3H]ZM241385 from human A2A receptor expressed in HEK293 cell membranes | 2018 | MedChemComm, Nov-01, Volume: 9, Issue:11
| Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A |
| AID313258 | Displacement of [3H]CGS21680 from adenosine A1 receptor in pig striatum membrane | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID1222901 | Drug transport in yeast assessed as recombinant human ENT1-mediated uptake at 1 uM measured over 2 to 60 mins by scintillation counting analysis in presence of uridine | 2013 | Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
| Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. |
| AID313264 | Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in CHO cells | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. |
| AID32151 | Agonistic activity against adenosine A1 receptor in guinea pig isolated hearts | 2004 | Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
| Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |